Advanced Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018

WinterGreen Research announces that it has published a new study Telemedicine. Market Shares, Strategy, and Forecasts, Worldwide, 2012 to 2018. The 2012 study has 590 pages, 206 tables and figures. Worldwide markets are poised to achieve significant growth as the telemedicine systems provide a way to improve clinical care delivery to patients with chronic disease, decreasing hospitalizations and visits to the emergency room.

Chronic disease conditions are best treated early on when there is a change in patient condition and an early intervention can make a difference. It is even better to treat them in a wellness treatment environment before there are indications of chronic disease, before symptoms develop, by addressing lifestyle issues early on.

Get the sample copy of this report : https://www.marketresearchreports.biz/sample/sample/100022

Left to their own judgments, some patients typically are apt to make terrible decisions relating to their personal health either because of ignorance, genetic inheritance, or because of lifestyle habit. The ability to accurately access patient condition via a combination of advanced testing and telemonitoring creates the opportunity to intervene when what is called for clinically can make a difference, and permits provision for education regarding healthy living in a way that is likely to create compliance with clinician recommendations.

Home telemonitoring programs need to use advanced technology. Effective monitors support patient education. They support timely clinician intervention based on real vital signs data gathered on a daily basis. Health care for patients with congestive heart failure has been shown to be successful in reducing hospitalizations and trips to the emergency department, making these critical measures unnecessary in many cases.

Home patient monitoring means two things: the imminent rise of the expert patient whom the health authorities anticipate would self-manage his long-term medical conditions and the prominence of mobile devices as the go-between for clinicians and patients.

View Full Report : https://www.marketresearchreports.biz/reports/100022/telemedicine-monitoring-shares-strategies-and-market-research-reports

Home patient monitoring means two things: the imminent rise of the expert patient whom the health authorities anticipate would self-manage his long-term medical conditions and the prominence of mobile devices as the go-between for clinicians and patients.

Telemedicine device and software companies recognize that their revenue stream will come from services delivery. Just as cell phones are paid for in conjunctions with the services contracts, so also the telemedicine applications will be paid by insurance. In some cases the insurance companies recognize that their long term costs are lower by delivering clinical intervention to try to impact lifestyle for patients with chronic disease conditions.

The telemedicine in the home is cheaper than the consequent emergency room visits and hospitalizations that occur if chronic conditions are ignored. There is a certain inevitability related to chronic disease condition care delivery. People that take care of themselves tend to stay healthy. People that are not attentive to protecting their health tend to have medical conditions that contribute to deteriorating health and benefit from early intervention when it is delivered in a manner to which the person can relate. Telemedicine is, at its core, a way to extend clinical services to make them part of lifestyle consultation. . It provides a way to initiate two way communications with a patient, forever changing the doctor - patient relationship to a collaborative one. It means that physicians need to build collaboration skills or delegate those to their nurses which they have always done, but this time in a more effective manner, on that is supported by technology.

Send an enquiry here : https://www.marketresearchreports.biz/sample/enquiry/100022

Telemedicine systems come from Honeywell, Vitarian, and Bosch Diagnostic Support Expert Systems. Tablets are poised to change telemedicine as are telepresence systems from Logitech among others. Clinical diagnosis is being impacted by the decision support systems. Clinical decision support systems (CDSS) have been a key aspect of telemedicine. Bosch offers the ability to track and update on a daily basis, questions that are able to address actual situations that patients face.

Diagnostic support expert systems promise to revolutionize healthcare. The mandated electronic health record (EHR) systems in all healthcare facilities, is a key enabler of diagnostic support expert systems.

The objectives are to promote better and cheaper healthcare using diagnostic support based on the patient data collected from the telemedicine systems. With the large amount of new data collected by the newly installed EHR systems, computers like the Watson will be able to find optimal answers to clinical questions much more efficiently than the human mind.

Two major categories are diagnostic support tools and treatment support tools. Chronic conditions requires continuous diagnostic support because a continuous flow of information on patient change in conditions helps physicians make a better diagnosis based on the patient symptoms, medications, and medical records.

Treatment support helps clinicians stay compliant with known treatment guidelines such as avoiding known drug interactions, dispensing the right medication to the right patients, and staying on schedule with response to changes in patient condition.

According to Susan Eustis, lead author of the WinterGreen Research team that prepared the telemedicine market research study, "Differential diagnostic tools support differential telemedical treatment. The decision process take into account clinical findings form the home monitoring devices and from symptoms verbally communicated in a clinical services implementation."

She continued, "Care delivery is enhanced by having clinicians be responsive to changes in patient condition that we know will lead to further patient deterioration if not treated immediately. A core part of responsible healthcare delivery is to use technology for healthcare reform. There is a focus on how to deliver care differently using telemedicine. No matter who pays for it, the use of telemedicine is anticipated to reduce the overall costs of healthcare delivery. Innovation is key to achieving improvements."

For long-term success, telehealth solutions require sustainable financing models. Investments in telehealth technologies foster sustainability by enabling productivity and efficiency gains and other improvements that can more than justify investment costs.

Government and local authorities have long recognized the potential of telehealth technology as a tool for delivering health and social care services. This is an increasing imperative given the increasing age demographic and the backdrop of static or reducing funding. Telehealth initiatives must demonstrate credibility and viability beyond the pilot and trial programs in order to achieve the goal of increased capability through technology.

Device installer partners define benefits in terms of increased sales and consultancy. A sustaining finance model is an essential aspect of telehealth. Telemedicine is analogous to the telecommunications industry where a large upfront investment is required an, usage models and complementary technologies must emerge and finally they must be integrated into existing healthcare service delivery paradigms.

Workflows are required to integrate the telehealth components into the existing solutions. This is possibly the area of greatest challenge. Upfront costs are high. Once the telehealth solution has been implemented initiatives are cost effective.

Since insurance companies have the responsibility for taking care of all people, not just the healthy ones and the health conscious people, they benefit from encouraging the use of telemedicine. The US veterans' administration recognizes this reality and has in place extensive telemedicine programs. While some hospitals benefit from an increase in hospitalizations, insurers do not.

There is a services component to the business that makes it attractive to sell the devices below cost. The tablet market revolutionizes telemedicine.

Once FDA approved software runs on a tablet, people with an existing unit can download software and be equipped with a way to interact with the clinical service that performs monitoring. Long term, the services will be a very attractive part of telemonitoring.

Telemedicine dedicated device and software markets at $736 million in 2011 are anticipated to reach $2.5 billion by 2018. Table devices typically cost $350 in 2011, with the average price of the software at $75 per unit. This means there is a services business that will pay for the devices over time.

Key Topics



Chronic heart failure
CHF
Chronic heart disease
Telehealth
Telemedicine
Telemonitoring
CMS Telemonitoring
Heart disease treatment efficacy
Care Management
CMHCB
Health Buddy System
Medicare Monitoring
Remote patient monitoring
Heart failure mortality
Health economics
Heart Failure
Heart Diseases
Cardiovascular Diseases
Behavior CHF patient
Behavior Modification
Telemedicine
Hypertension monitoring
Chronic heart disease telemonitoring
Health care delivery efficacy
Chronic Diseases Monitoring
Health Services and Systems
Telehealth
DRE
Health Monitoring
Health Communication
Aging
Monitoring Technology
Health engagement
Medical innovation
Mobile health
Remote health monitoring
Clinical communication
Medical communication
Telemedicine
Telehealth
Tele-health
Remote medical support
Telepharmacy
Seniors and health
Diabetes Monitoring
Telemedicine
Remote patient monitoring
Chronic heart failure mortality
health economics
Heart Failure
Heart Diseases
Cardiovascular Diseases
Quality of Care
American Medical Group Association
Department of Veterans Affairs telemonitoring
Chronic disease management
Health Buddy System Healthcare telemonitoring
Medicare telemonitoring
Bosch telehealth
Treatment Monitoring
Companies Profiled
Market Leaders
Bayer HealthCare / Viterion TeleHealthcare
Care Innovation / Intel® GE Care Innovations
Philips
Bosch Group
Market Participants
A&D Engineering / A&D Medical
Aerotel Medical Systems
American Heart Association (AHA)
American TeleCare
American Telemedicine Association
Apple
AT&T
Athens Regional Home Health In-Home Telemonitoring Services
Authentidate Holding
Axon
Bayer AG / Bayer HealthCare
Biotronik
Bosch Group
Cardiocom
Care Innovations: Intel and GE
Columbia University's Informatics for Diabetes Education and Telemedicine
Connections365
Continua
Debiotech
Evident Health Services
FuzeBox
Gemalto / Cinterion
Home Healthcare Hospice and Community Services (HCS)
Honeywell
Infopia
Johns Hopkins Launch Home Telemonitoring Education Initiative
JSC CEM Technology
Kiwok
LG
LifeMasters
Logitech / LifeSize
McKesson
MedApps
Medtronic
Montefiore / CMO, the Care Management Company
National Committee for Quality Assurance
Nonin Medical, Inc.
Partners Healthcare
Partners Healthcare Center for Connected Health
Philips
ProConnections, Inc.
REACH Health, Inc.
RS TechMedic BV
Samsung
Sandata Technologies, Inc.
STMicroelectronics
TeleAtrics™
Trifecta Technologies
TouchPointCare
Tunstall Healthcare Group
AMAC / Intel® Health Guide
University of Houston
Verizon Technologies
Veteran's Administration (VA)
VIDAVO S.A
Virtual Health
Vodafone
VRI
Windstream

MRRbiz supports your business intelligence needs with over 700,000 market research reports, company profiles, data books, and regional market data sheets in its repository. Our document database is updated by the hour, which means that you always have access to fresh data spanning over 300 industries and their sub-segments.

State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
(USA-Canada)

Tel: +1-518-621-2074
E: sales@marketresearchreports.biz

This release was published on openPR.